These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 15570080)

  • 41. Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience.
    Nathan PC; Tsokos M; Long L; Bernstein D; Wexler LH; Mackall CL; Helman LJ
    Pediatr Blood Cancer; 2005 May; 44(5):449-54. PubMed ID: 15547929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensive chemotherapy for children and young adults with metastatic primitive neuroectodermal tumors of the soft tissue.
    Bisogno G; Carli M; Stevens M; Oberlin O; Treuner J; Scarzello G; Colombatti R; De Zen L; Pinkerton CR
    Bone Marrow Transplant; 2002 Sep; 30(5):297-302. PubMed ID: 12209351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
    Douglas JG; Arndt CA; Hawkins DS
    Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
    J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival after recurrence of Ewing's sarcoma family of tumors.
    Barker LM; Pendergrass TW; Sanders JE; Hawkins DS
    J Clin Oncol; 2005 Jul; 23(19):4354-62. PubMed ID: 15781881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
    Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
    Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B
    Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
    Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
    Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors.
    Zacharoulis S; Ji L; Pollack IF; Duffner P; Geyer R; Grill J; Schild S; Jaing TH; Massimino M; Finlay J; Sposto R
    Pediatr Blood Cancer; 2008 Feb; 50(2):231-5. PubMed ID: 17610266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synovial sarcoma: the importance of size and location for survival.
    Deshmukh R; Mankin HJ; Singer S
    Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiosarcoma of the breast.
    Vorburger SA; Xing Y; Hunt KK; Lakin GE; Benjamin RS; Feig BW; Pisters PW; Ballo MT; Chen L; Trent J; Burgess M; Patel S; Pollock RE; Cormier JN
    Cancer; 2005 Dec; 104(12):2682-8. PubMed ID: 16288486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
    Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
    Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES).
    Haeusler J; Ranft A; Boelling T; Gosheger G; Braun-Munzinger G; Vieth V; Burdach S; van den Berg H; Juergens H; Dirksen U
    Cancer; 2010 Jan; 116(2):443-50. PubMed ID: 19924786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.